Related Experiment Video

Updated: Apr 22, 2026

Simultaneous Isolation of High Quality Cardiomyocytes, Endothelial Cells, and Fibroblasts from an Adult Rat Heart
09:38

Simultaneous Isolation of High Quality Cardiomyocytes, Endothelial Cells, and Fibroblasts from an Adult Rat Heart

Published on: May 19, 2017

13.4K

The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism

Javier Inserte1, David Garcia-Dorado

  • 1Cardiology Department, Vall d'Hebron University Hospital and Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.

British Journal of Pharmacology
|October 10, 2014
PubMed

Insights

Ischaemic postconditioning preserves the cGMP/PKG pathway, reducing cardiomyocyte death during reperfusion injury. Stimulating this pathway offers a promising therapeutic target for myocardial infarction treatment.

Area of Science:

  • Cardiovascular Science
  • Cellular Biology
  • Pharmacology

Background:

  • Myocardial reperfusion injury leads to cardiomyocyte cell death and infarct expansion after coronary occlusion.
  • Key injury mechanisms include altered calcium handling, sarcoplasmic reticulum dysfunction, calpain activation, and mitochondrial permeability transition.
  • These events, occurring early in reperfusion, are mitigated by intracellular acidosis.

Purpose of the Study:

  • To review the mechanisms of ischaemic postconditioning on the cGMP/PKG pathway.
  • To explore pharmacological strategies targeting the cGMP/PKG pathway during reperfusion.
  • To assess the clinical translation potential of these strategies for myocardial infarction.

Main Methods:

  • Review of preclinical and clinical studies on ischaemic postconditioning and the cGMP/PKG pathway.
  • Analysis of mechanisms linking cGMP/PKG to intracellular pH, calcium handling, and mitochondrial function.
  • Evaluation of pharmacological agents designed to activate the cGMP/PKG pathway.

Main Results:

  • The cGMP/PKG pathway modulates intracellular pH recovery and directly impacts calcium oscillations and mitochondrial permeability.
  • Ischaemia/reperfusion depresses the cGMP/PKG pathway, while ischaemic postconditioning preserves it, contributing to cardioprotection.
  • Pharmacological stimulation of cGMP/PKG during reperfusion shows preclinical promise.

Conclusions:

  • Modulation of the cGMP/PKG pathway is a significant factor in postconditioning-mediated cardioprotection.
  • Targeting the cGMP/PKG pathway represents a potential therapeutic strategy for managing myocardial infarction.
  • Further clinical translation is warranted to validate these promising findings.

More Related Videos

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter05:04

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

2.9K
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

1.8K

Related Concept Videos

Global Regulatory Systems01:28

Global Regulatory Systems

Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
942
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.2K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.7K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.4K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
113